FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to a medicinal composition in liquid form, which is placed in a soft capsule, as well as to a medicament in soft capsules. Capsule shell contains succinylated gelatin as the main component. Claimed composition comprises (a) one type of phenol derivative or a mixture of different types thereof and (b) a succinylated gelatinous solubility reducing agent.
EFFECT: implementation of the invention enables to obtain a medicinal composition capable of preventing the dissolution of the shell by its contents (drug) even when a phenol derivative is placed in an encapsulated capsule.
6 cl, 14 tbl, 41 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CAPSULES CONTAINING WATER FILLING COMPOSITIONS, STABILISED WITH DERIVATIVE OF CYCLODEXTRIN | 2003 |
|
RU2359698C2 |
| ORAL COMPOSITION COMPRISING DIFFICULTLY WATER-SOLUBLE ACTIVE SUBSTANCE SOLID SOLUTION | 2003 |
|
RU2314811C2 |
| DOSAGE FORMS IN FORM OF CAPSULES | 2019 |
|
RU2824998C2 |
| SELF-EMULSIFYING COMPOSITION FOR SCARCELY WATER-SOLUBLE MEDICAMENT | 1999 |
|
RU2257917C2 |
| PHARMACEUTICAL DOSAGE FORM FOR SIMETICONE AND LOPERAMIDE EMULSION | 2019 |
|
RU2788873C2 |
| PHARMACEUTICAL COMPOSITIONS | 2005 |
|
RU2447885C2 |
| LIPID COMPOSITIONS OF RACECADOTRIL | 2013 |
|
RU2632441C2 |
| RACECADOTRIL LIPID COMPOSITIONS | 2014 |
|
RU2662069C2 |
| SUSTAINABLE STRUCTURES OF ANTITHROMBOCYTIC AGENTS, OMEGA-3 FATTY ACIDS AND AMYLOSE IN SOFT GELATIN CAPSULES | 2012 |
|
RU2630606C2 |
| CAPSULE COMPOSITION | 2013 |
|
RU2642934C2 |
